쎌바이오텍 사업보고서 (2017.12)
1. 요약재무정보

가. 요약연결재무정보

구 분	제 23기	제 22기	제 21기

(2017년12월말)	(2016년12월말)	(2015년12월말)

[유동자산]	70,869,117,667	69,267,535,256	54,150,513,012

·현금및현금성자산	13,616,318,074	10,594,468,521	7,272,875,829

·매출채권및기타유동채권	7,572,078,217	10,792,304,471	9,311,574,554

·금융상품자산	27,964,940,749	45,198,950,000	34,606,184,587

·단기투자자산	18,026,799,345	-	-

·재고자산	2,810,036,561	2,052,900,092	2,521,478,081

·기타유동자산	869,850,675	628,912,172	438,399,961

·당기법인세자산	9,094,046	-	-

[비유동자산]	25,607,600,999	21,261,696,865	20,817,336,026

·장기매출채권및기타비유동채권	674,808,342	342,479,173	264,874,621

·금융상품자산	5,000,000	5,000,000	505,000,000

·장기투자증권	289,770,613	266,592,405	287,043,173

·유형자산	23,182,209,000	19,524,253,609	18,780,486,861

·무형자산	1,099,824,876	939,269,664	843,148,796

·이연법인세자산	355,988,168	184,102,014	136,782,575

자 산 총 계	96,476,718,666	90,529,232,121	74,967,849,038

[유동부채]	6,259,373,000	6,360,902,280	6,163,135,072

[비유동부채]	20,952,000	15,476,000	47,462,020

부 채 총 계	6,280,325,000	6,376,378,280	6,210,597,092

[지배기업 소유주지분]	90,196,393,666	84,152,853,841	68,757,251,946

[자본금]	4,700,000,000	4,700,000,000	4,700,000,000

[자본잉여금]	12,759,754,094	12,759,754,094	12,759,754,094

[자본조정]	(12,921,092,595)	(5,260,426,445)	(5,260,426,445)

[기타포괄손익누계액]	(214,287,866)	33,453,542	48,368,033

[이익잉여금]	85,872,020,033	71,920,072,650	56,509,556,264

[비지배지분]	-	-	-

자 본 총 계	90,196,393,666	84,152,853,841	68,757,251,946

기 간	(2017.01.01~	(2016.01.01~	(2015.01.01~

2017.12.31)	2016.12.31)	2015.12.31)

매출액	61,056,741,253	58,275,830,849	49,504,515,603

영업이익	22,632,702,571	21,561,007,533	18,758,807,947

당기순이익	18,197,947,383	18,498,516,386	17,505,140,264

지배기업 소유주지분	17,950,205,975	18,483,601,895	17,505,140,264

비지배지분	-	-	-

주당순이익	2,412	2,396	2,268

연결에포함된회사수	4	3	3

나.요약별도재무정보

구 분	제 23기	제 22기	제 21기

(2017년12월말)	(2016년12월말)	(2015년12월말)

[유동자산]	71,712,275,488	68,130,327,104	53,860,925,500

·현금및현금성자산	6,288,562,192	10,048,170,009	6,822,021,385

·매출채권및기타유동채권	16,356,908,532	11,300,441,465	10,418,352,866

·금융상품자산	27,464,940,749	44,298,950,000	33,706,184,587

·투자자산	18,026,799,345	-	-

·재고자산	2,764,048,367	1,995,382,673	2,488,101,480

·기타유동자산	811,016,303	487,382,957	426,265,182

[비유동자산]	27,469,510,652	23,717,557,562	22,233,829,427

·장기매출채권및기타비유동채권	37,850,411	37,850,411	8,850,411

·금융상품자산	5,000,000	5,000,000	505,000,000

·투자자산	180,905,497	166,528,857	224,009,929

·종속기업투자	4,302,157,020	3,218,445,020	2,118,819,740

·유형자산	21,915,792,909	19,386,662,974	18,616,137,994

·무형자산	839,671,388	775,249,663	689,416,428

·이연법인세자산	188,133,427	127,820,637	71,594,925

자 산 총 계	99,181,786,140	91,847,884,666	76,094,754,927

[유동부채]	6,362,057,497	6,216,204,771	5,415,695,302

[비유동부채]	25,952,000	20,476,000	47,677,600

부 채 총 계	6,388,009,497	6,236,680,771	5,463,372,902

[자본금]	4,700,000,000	4,700,000,000	4,700,000,000

[자본잉여금]	12,759,754,094	12,759,754,094	12,759,754,094

[자본조정]	(12,921,092,595)	(5,260,426,445)	(5,260,426,445)

[기타포괄손익누계액]	(151,640,166)	(592,760)	(3,298,882)

[이익잉여금]	88,406,755,310	73,412,469,006	58,435,353,258

자 본 총 계	92,793,776,6	85,611,203,895	70,631,382,025

종속ㆍ관계ㆍ공동기업 투자주식의 평가방법	원가법	원가법	원가법

기 간	(2017.01.01~	(2016.01.01~	(2015.01.01~

2017.12.31)	2016.12.31)	2015.12.31)

매출액	58,870,733,529	56,495,596,508	49,024,773,708

영업이익	23,753,053,899	21,126,350,787	19,214,527,103

당기순이익	19,240,286,304	18,065,115,748	17,330,744,519

주당순이익	2,550	2,340	2,245